Kieran Gallahue
President, ResMed.
Companies
- Envista Holdings CorporationBoard member Dec 20, 2019 to now1
- Edwards LifesciencesBoard member Feb 17, 2015 to now2
- Intersect ENTBoard member Apr 10, 2015 to May 16, 20223
- Arena PharmaceuticalsBoard member Jul 10, 2018 to Mar 11, 20224
- Intersect ENTChair May 8, 2019 to Oct 2, 20195
- ResMedBoard member Sep 2, 2008 to Jan 7, 20116
- ResMedChief executive officer Sep 2, 2008 to Jan 7, 20116
- ResMedPresident Feb 10, 2006 to Nov 13, 20077
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Edwards Lifesciences EW83,971 shares8$7.3M at $87.49May 8, 2026Envista Holdings Corporation NVST54,010 shares9$1.2M at $22.71May 19, 2026
Arena Pharmaceuticals ARNA0 shares10Mar 11, 2022
Intersect ENT XENT0 shares11May 13, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- May 19, 2026Granted 9,330 shares of Envista Holdings Corporation9
- May 8, 2026Granted 1,064 shares of Edwards Lifesciences8
- May 8, 2026Granted 3,251 shares of Edwards Lifesciences8
- Jun 10, 2025Granted 10,450 shares of Envista Holdings Corporation12
- May 9, 2025Granted 1,154 shares of Edwards Lifesciences13
- May 9, 2025Granted 3,528 shares of Edwards Lifesciences13
- May 21, 2024Granted 10,085 shares of Envista Holdings Corporation14
- May 8, 2024Granted 999 shares of Edwards Lifesciences15
- May 8, 2024Granted 3,055 shares of Edwards Lifesciences15
- Feb 23, 2024Sold 3,058 shares at $87.61 of Edwards Lifesciences16
- Feb 23, 2024Gift 7,056 shares of Edwards Lifesciences16
- Feb 23, 2024Gift 7,056 shares of Edwards Lifesciences16
- Feb 23, 2024Exercised options 7,056 shares at $36.86 of Edwards Lifesciences16
- May 23, 2023Granted 5,425 shares of Envista Holdings Corporation17
- May 12, 2023Granted 898 shares of Edwards Lifesciences18
- May 12, 2023Granted 2,803 shares of Edwards Lifesciences18
- May 24, 2022Granted 4,435 shares of Envista Holdings Corporation19
- May 13, 2022U 29,262 shares at $28.25 of Intersect ENT11
- May 13, 2022U 5,011 shares at $28.25 of Intersect ENT11
- May 13, 2022U 3,239 shares at $28.25 of Intersect ENT11
- May 4, 2022Granted 737 shares of Edwards Lifesciences20
- May 4, 2022Granted 2,300 shares of Edwards Lifesciences20
- Mar 11, 2022Other 8,167 shares of Arena Pharmaceuticals10
- Mar 11, 2022Other 1,116 shares of Arena Pharmaceuticals10
- Mar 11, 2022Other 3,628 shares of Arena Pharmaceuticals10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGAREdwards Lifesciences, Board member
- 3SEC EDGARIntersect ENT, Board member
- 4SEC EDGARArena Pharmaceuticals, Board member
- 5SEC EDGARIntersect ENT, Chair
- 6SEC EDGARResMed, Board member
- 7SEC EDGARResMed, President
- 8
- 9
- 10
- 11
- 12SEC EDGARForm 4 filed Jun 12, 2025
- 13SEC EDGARForm 4 filed May 9, 2025
- 14SEC EDGARForm 4 filed May 23, 2024
- 15SEC EDGARForm 4 filed May 9, 2024
- 16SEC EDGARForm 4 filed Feb 26, 2024
- 17SEC EDGARForm 4 filed May 25, 2023
- 18SEC EDGARForm 4 filed May 15, 2023
- 19SEC EDGARForm 4 filed May 31, 2022
- 20SEC EDGARForm 4 filed May 10, 2022